MedDataX Logo

Effect of Physician Attire on Patients' Preference of Physician

NCT ID: NCT03168763

Last Updated: 2020-11-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

108 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-09-25

Study Completion Date

2020-10-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this research study is to learn about the effects of a doctor's characteristics on participant's preference for a doctor. Researchers also want to learn about how a doctor's characteristics affect participant's options about professionalism and compassion.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

If participant agrees to take part in this study, participant will be asked to complete 7 questionnaires. These questionnaires ask about participant's gender, date of birth, ethnicity, marital status, level of education, religion, and information about the disease and treatments participant received. Participant will also be asked about any symptoms participant may be having, how much trust participant has in the medical profession in general, how participant feels about the disease, any depression or anxiety participant may have, and participant's level of hopefulness. These questionnaires should take about 6 minutes to complete.

Participant will be shown 2 videos (each 3 minutes long) and then participant will complete questions about each video. Participant will be asked to rate the doctors participant saw on their professionalism and their compassion.

Caregivers will be required to leave the room or stay silent while the participant is watching the videos.

The total time to watch the videos and complete the second set of questionnaires should be about 7 minutes.

Finally, participant will be asked to complete 3 questionnaires about participant's overall preference for a doctor. These questionnaires will take about 5 minutes to complete.

Length of Study Participation:

Participation in this study is complete after participant answers the final questionnaires.

Overall, this study should take about 30 minutes to complete.

This is an investigational study.

Up to 108 participants will be enrolled in this study. All will take part at MD Anderson.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Malignant Neoplasms of Independent (Primary) Multiple Sites

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Malignant neoplasms of independent (primary) multiple sites Advanced Cancer Videos Questionnaires Surveys

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Video 1A

Questionnaires completed at baseline, after each video viewing, and at completion.

Participants shown Video 1A or 1B, then shown Video 2A or 2B.

Group Type EXPERIMENTAL

Video

Intervention Type BEHAVIORAL

Participants shown Video 1A or 1B, then shown Video 2A or 2B.

Questionnaires

Intervention Type BEHAVIORAL

Questionnaires completed at baseline, after each video viewing, and at completion.

Video 1B

Questionnaires completed at baseline, after each video viewing, and at completion.

Participants shown Video 1A or 1B, then shown Video 2A or 2B.

Group Type EXPERIMENTAL

Video

Intervention Type BEHAVIORAL

Participants shown Video 1A or 1B, then shown Video 2A or 2B.

Questionnaires

Intervention Type BEHAVIORAL

Questionnaires completed at baseline, after each video viewing, and at completion.

Video 2A

Questionnaires completed at baseline, after each video viewing, and at completion.

Participants shown Video 1A or 1B, then shown Video 2A or 2B.

Group Type EXPERIMENTAL

Video

Intervention Type BEHAVIORAL

Participants shown Video 1A or 1B, then shown Video 2A or 2B.

Questionnaires

Intervention Type BEHAVIORAL

Questionnaires completed at baseline, after each video viewing, and at completion.

Video 2B

Questionnaires completed at baseline, after each video viewing, and at completion.

Participants shown Video 1A or 1B, then shown Video 2A or 2B.

Group Type EXPERIMENTAL

Video

Intervention Type BEHAVIORAL

Participants shown Video 1A or 1B, then shown Video 2A or 2B.

Questionnaires

Intervention Type BEHAVIORAL

Questionnaires completed at baseline, after each video viewing, and at completion.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Video

Participants shown Video 1A or 1B, then shown Video 2A or 2B.

Intervention Type BEHAVIORAL

Questionnaires

Questionnaires completed at baseline, after each video viewing, and at completion.

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Surveys

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Advanced cancer diagnosis (locally advanced, recurrent or metastatic disease).
2. Patients presenting as follow-ups only at the outpatient Supportive Care Center.
3. Age \>/= 18 years-old
4. English speaking

Exclusion Criteria

1. Altered cognition (as assessed routinely in the Supportive Care Clinic using the Memorial Delirium Assessment Scale (MDAS), with a score of \>/= 7/30).
2. Patients suffering from a severe psychiatric disorder or condition that would significantly interfere with study participation.
3. Patients with hearing and/or visual impairments.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

M.D. Anderson Cancer Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ahsan Azhar, MD

Role: PRINCIPAL_INVESTIGATOR

M.D. Anderson Cancer Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Texas MD Anderson Cancer Center

Houston, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

http://www.mdanderson.org

University of Texas MD Anderson Cancer Center Website

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NCI-2018-01195

Identifier Type: REGISTRY

Identifier Source: secondary_id

2016-0970

Identifier Type: -

Identifier Source: org_study_id